We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
Sandbox Reserved 431
From Proteopedia
(Difference between revisions)
| Line 17: | Line 17: | ||
===Binding Interactions=== | ===Binding Interactions=== | ||
| - | -This | + | -This <scene name='Sandbox_Reserved_431/Ligand/1'>Ligand</scene> is a competitive inhibitor |
| - | - | + | |
| + | -It has good selectivity over other phosphatases | ||
-Ligand binds via 2 binding sites | -Ligand binds via 2 binding sites | ||
Revision as of 03:29, 5 March 2012
| This Sandbox is Reserved from January 19, 2016, through August 31, 2016 for use for Proteopedia Team Projects by the class Chemistry 423 Biochemistry for Chemists taught by Lynmarie K Thompson at University of Massachusetts Amherst, USA. This reservation includes Sandbox Reserved 425 through Sandbox Reserved 439. |
Contents |
Phosphatase Inhibitor complexes: pdb 1nny
|
Introduction
Overall Structure
Binding Interactions
-This is a competitive inhibitor
-It has good selectivity over other phosphatases
-Ligand binds via 2 binding sites
Additional Features
Credits
Introduction - Jill Carlson
Overall Structure - Polina Berdnikova
Drug Binding Site - Brett Clinton
Additional Features - James Hamblin
